STOCK TITAN

IDEXX (NASDAQ: IDXX) director Hooley granted deferred units and options

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IDEXX Laboratories director Joseph L. Hooley reported new equity awards. On May 12, 2026, he received 234 deferred stock units and 525 non-qualified stock options. The options have an exercise price of $533.92 per share and expire on May 11, 2036.

Both the deferred stock units and the options vest in a single installment on the one-year anniversary of the grant date or on the date of the 2027 annual meeting of shareholders, whichever occurs earlier. The deferred stock units are generally payable in common stock after Mr. Hooley resigns from the board.

Positive

  • None.

Negative

  • None.
Insider HOOLEY JOSEPH L
Role null
Type Security Shares Price Value
Grant/Award Non-Qualified Stock Option (right-to-buy) 525 $0.00 --
Grant/Award Deferred Stock Unit 234 $0.00 --
Holdings After Transaction: Non-Qualified Stock Option (right-to-buy) — 525 shares (Direct, null); Deferred Stock Unit — 234 shares (Direct, null)
Footnotes (1)
  1. Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier. Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.
Deferred stock units granted 234 units Grant to director Joseph L. Hooley on May 12, 2026
Stock options granted 525 options Non-qualified options granted on May 12, 2026
Option exercise price $533.92 per share Non-qualified stock option strike price
Option expiration date May 11, 2036 Non-qualified stock option term end
Total DSUs after grant 234 units Total deferred stock units following transaction
Total options after grant 525 options Total non-qualified stock options following transaction
Deferred Stock Unit financial
"security_title: Deferred Stock Unit; each unit is a contingent right to receive stock"
A deferred stock unit (DSU) is a promise from a company to give an employee or director the value of a share at a future date, paid in actual shares or cash when certain conditions are met (such as retirement or a set date). Think of it like a gift card that converts to company stock later; it aligns pay with long‑term performance and can affect future share count, compensation expense and potential cash needs, so investors watch DSUs for their impact on dilution and company finances.
Non-Qualified Stock Option (right-to-buy) financial
"security_title: Non-Qualified Stock Option (right-to-buy) with a fixed exercise price"
contingent right financial
"Each deferred stock unit represents a contingent right to receive one share"
annual meeting of shareholders financial
"Awards vest on the one year anniversary or on the 2027 annual meeting of shareholders"
A yearly gathering where a company’s owners (shareholders) vote on key items like electing the board, approving executive pay, and ratifying auditors, and receive updates on performance and strategy. Think of it as an annual town hall for owners: it matters to investors because outcomes and disclosures can affect leadership, corporate direction, dividend and governance policies, and therefore the company’s risk and potential return.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
HOOLEY JOSEPH L

(Last)(First)(Middle)
ONE IDEXX DRIVE

(Street)
WESTBROOK MAINE 04092

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
IDEXX LABORATORIES INC /DE [ IDXX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
05/12/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Non-Qualified Stock Option (right-to-buy)$533.9205/12/2026A525 (1)05/11/2036Common Stock525$0525D
Deferred Stock Unit(2)05/12/2026A234 (2) (2)Common Stock234$0234D
Explanation of Responses:
1. Grant of option to buy shares of Issuer common stock that vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier.
2. Each deferred stock unit represents a contingent right to receive one share of Issuer common stock. These deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2027 annual meeting of shareholders, whichever event is earlier, and by default are payable as common stock as soon as practicable following the date of the Director's resignation from the Board of Directors.
Remarks:
/s/ Lily J. Lu, Attorney-in-Fact for Joseph L. Hooley05/14/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transactions did IDEXX (IDXX) director Joseph L. Hooley report?

Joseph L. Hooley reported equity awards, not open-market trades. He received 234 deferred stock units and 525 non-qualified stock options as director compensation, all granted on May 12, 2026, according to the Form 4 insider filing data.

How many deferred stock units did IDEXX (IDXX) grant to director Hooley?

IDEXX granted Joseph L. Hooley 234 deferred stock units. Each unit represents a contingent right to receive one share of IDEXX common stock, subject to vesting and payment terms linked to his board service and eventual resignation from the Board of Directors.

What stock options did IDEXX (IDXX) director Hooley receive in this Form 4?

Hooley received 525 non-qualified stock options to buy IDEXX common stock. These options carry an exercise price of $533.92 per share and expire on May 11, 2036, providing long-term equity-based compensation tied to the company’s share performance.

When do Joseph L. Hooley’s IDEXX (IDXX) stock options and deferred stock units vest?

Both awards vest in a single installment. Vesting occurs either one year after the May 12, 2026 grant date or on the date of IDEXX’s 2027 annual meeting of shareholders, whichever event happens earlier, aligning vesting with Hooley’s board service period.

How and when are IDEXX (IDXX) deferred stock units payable to director Hooley?

The deferred stock units are, by default, payable in IDEXX common stock. Payment occurs as soon as practicable after Joseph L. Hooley resigns from the Board of Directors, so the value realization is generally deferred until the end of his board tenure.

Does the IDEXX (IDXX) Form 4 show any stock purchases or sales by Hooley?

The Form 4 does not show open-market purchases or sales. It reports two grant-type acquisitions: 234 deferred stock units and 525 non-qualified stock options, both awarded at a transaction price of $0.00 per unit as part of director compensation.